Head to Head Survey: Varian Medical Systems (VAR) & Its Competitors
Varian Medical Systems (NYSE: VAR) is one of 80 publicly-traded companies in the “Advanced Medical Equipment & Technology” industry, but how does it compare to its peers? We will compare Varian Medical Systems to similar businesses based on the strength of its risk, institutional ownership, profitability, dividends, earnings, analyst recommendations and valuation.
This is a summary of current ratings and recommmendations for Varian Medical Systems and its peers, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Varian Medical Systems||2||7||1||0||1.90|
|Varian Medical Systems Competitors||271||1878||3374||108||2.59|
Varian Medical Systems currently has a consensus price target of $97.83, suggesting a potential downside of 10.27%. As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 7.91%. Given Varian Medical Systems’ peers stronger consensus rating and higher probable upside, analysts clearly believe Varian Medical Systems has less favorable growth aspects than its peers.
This table compares Varian Medical Systems and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Varian Medical Systems||8.85%||23.68%||10.74%|
|Varian Medical Systems Competitors||-312.53%||-28.44%||-10.33%|
Insider and Institutional Ownership
99.2% of Varian Medical Systems shares are owned by institutional investors. Comparatively, 50.4% of shares of all “Advanced Medical Equipment & Technology” companies are owned by institutional investors. 0.9% of Varian Medical Systems shares are owned by insiders. Comparatively, 18.4% of shares of all “Advanced Medical Equipment & Technology” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Volatility & Risk
Varian Medical Systems has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500. Comparatively, Varian Medical Systems’ peers have a beta of 1.29, indicating that their average stock price is 29% more volatile than the S&P 500.
Earnings and Valuation
This table compares Varian Medical Systems and its peers gross revenue, earnings per share and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Varian Medical Systems||$2.67 billion||$249.60 million||39.50|
|Varian Medical Systems Competitors||$2.13 billion||$229.91 million||-33.77|
Varian Medical Systems has higher revenue and earnings than its peers. Varian Medical Systems is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Varian Medical Systems beats its peers on 7 of the 13 factors compared.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product.
Receive News & Stock Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related stocks with our FREE daily email newsletter.